Why Diverse Patient Recruitment Matters in Trials
From the article
Recruitment and retention remain the two hardest problems in clinical research, and they are getting harder. For pharmaceutical sponsors and CRO clinical operations leaders running Phase II and III studies, weak clinical trial patient recruitment delays timelines, inflates costs, and produces...
Continue reading on fomatmedical.comYou might also wanna read
Embedded Clinical Trials: 7 Top Partners for 2026
fomatmedical.com·7d ago
How to Build Diverse Trial Recruitment in 2026
fomatmedical.com·8d ago
What Makes Diverse Trial Recruitment Hard for Sponsors
fomatmedical.com·8d ago
Phase II and III Trials: Top Clinical Service Partners for 2026
fomatmedical.com·8d ago
Sponsor Recruitment Support: How to Expand Trial Access Through Community Clinics
fomatmedical.com·8d ago
9 Patient Recruitment Services for Community Clinics
fomatmedical.com·9d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.